FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

20583711000001100: Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Jun 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1986561000001116 Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1986571000001114 Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) Is a Compound magnesium trisilicate 250 mg tablet false Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) Has active ingredient Magnesium trisilicate true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) Has specific active ingredient Magnesium trisilicate false Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) Has specific active ingredient Aluminium hydroxide dried false Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) Is a Magnesium trisilicate compound tablets false Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) Has specific active ingredient Aluminium hydroxide dried true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) Has specific active ingredient Magnesium trisilicate true Inferred relationship Existential restriction modifier
Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) Is a Magnesium trisilicate compound tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) 100 tablet Has AMP True Magnesium trisilicate compound tablets (Dalkeith Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start